Schrödinger Q4 software revenue $38.6M, up 55% YoY; guides 2022 total revenue $161-181M

Schrodinger, Inc.

2022-FY EPS reported -$1.42 revenue$137,931,000

Q4 total revenue $46.2M (+40% YoY); software revenue $38.6M (+55% YoY); drug discovery $7.6M.
FY 2021 total revenue $137.9M (+28% YoY); net loss $101.2M vs $26.6M loss in 2020.
2022 guidance: total revenue $161-181M; software $126-136M; drug discovery $35-45M; gross margin mid-70s%.
Karen Akinsanya promoted to president of R&D; MALT1 IND H1 2022; Phase 1 study in H2 2022.
Cash $579M; ACV $112.1M (+22% YoY); 190 customers >$100k ACV.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.